CRL

NYSEStock

Charles River Laboratories International, Inc.

$155.04-13.83 (-8.19%)

52-Week Range

$99.75

$226.77

Key Stats

Market Cap

7.6B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.65

Volume

785.1K

Avg Volume

1.1M

Performance

-8.03%

-22.96%

+0.28%

YTD

-24.58%

-8.55%

-25.54%

-47.74%

Price Chart

ETF Exposure

CRL is held by 208 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	22	$4K	$81.5M	0.10%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	107	$18K	$733.2M	0.20%
AVTM	Avantis Total Equity Markets ETF 1	0.00%	39	$7K	$694.1M	0.23%
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	2	$271	$9.0M	0.30%
LVHB	Innovator Laddered Allocation Power Buffer ETF	0.00%	382	$73K	$782.6M	0.10%
STHE.L	PIMCO US Short-Term High Yield Corporate Bond UCITS ETF	0.00%	1	$17K	$1.79B	0.60%
FTLS	First Trust Long/Short Equity ETF	0.00%	0	$0	$2.16B	1.38%
IQSM	NYLI Candriam U.S. Mid Cap Equity ETF	0.00%	4,954	$0	$207.8M	0.15%

PreviousPage 5 of 5

About CRL ETF Exposure

Charles River Laboratories International, Inc. (CRL) is held by 208 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 7.6B, CRL is a widely held institutional stock. The stock currently trades at $155.04. Investors can gain exposure to CRL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CRL, sorted by portfolio weight.